Assessment of cyclooxygenase-1 and 2 gene expression levels in chronic autoimmune thyroiditis, papillary thyroid carcinoma and nontoxic nodular goitre.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4292998)

Published in Thyroid Res on December 17, 2014

Authors

Kinga Krawczyk-Rusiecka1, Katarzyna Wojciechowska-Durczynska1, Anna Cyniak-Magierska2, Arkadiusz Zygmunt1, Andrzej Lewinski1

Author Affiliations

1: Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Rzgowska St. No. 281/289, 93-338 Lodz, Poland.
2: Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell (1995) 6.69

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res (2000) 4.18

Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res (2007) 1.75

Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest (1999) 1.45

Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens) (2010) 1.10

Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am J Clin Pathol (2002) 1.02

Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope (2002) 0.98

Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clin Croat (2009) 0.96

Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol (2011) 0.95

Cyclooxygenase-2 expression in thyroid neoplasms. Histopathology (2003) 0.94

Cyclooxygenase-2 expression in thyroid nodules. J Clin Endocrinol Metab (2002) 0.93

VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr Relat Cancer (2006) 0.92

15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Prostaglandins Other Lipid Mediat (2006) 0.92

Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Future Oncol (2010) 0.86

Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland. Virchows Arch (2005) 0.86

[Cyclooxygenase and prostanoids--biological implications]. Postepy Hig Med Dosw (Online) (2006) 0.86

Cyclooxygenase-2 expression in human thyroid disease. J Endocrinol Invest (2008) 0.85

Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR. Thyroid Res (2010) 0.83

Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness. Thyroid (2013) 0.82

An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes. Endocr Pathol (2002) 0.81

Expression of cyclooxygenase-2 and thromboxane synthase in non-neoplastic and neoplastic thyroid lesions. Endocr Pathol (2004) 0.80

COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB). Thyroid Res (2011) 0.78

Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma? Neuro Endocrinol Lett (2011) 0.78

Cyclooxygenase 1 and 2 expressions in the human thyroid gland. Eur Arch Otorhinolaryngol (2005) 0.77